Citadel Advisors - GALERA THERAPEUTICS INC ownership

GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 48 filers reported holding GALERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GALERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,224
-99.0%
12,700
-82.7%
0.00%
Q2 2023$229,623
+103.4%
73,597
+66.9%
0.00%
Q1 2023$112,896
+132.5%
44,100
+35.3%
0.00%
Q4 2022$48,550
-81.0%
32,584
-77.9%
0.00%
Q3 2022$256,000
+20.2%
147,252
-9.8%
0.00%
Q2 2022$213,000
-72.3%
163,330
-49.3%
0.00%
Q1 2022$768,000
-7.2%
322,284
+78.6%
0.00%
Q4 2021$828,000180,5000.00%
Other shareholders
GALERA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 613,223$2,815,0000.83%
Sofinnova Investments, Inc. 3,083,712$14,154,0000.83%
Novo Holdings A/S 2,459,021$11,287,0000.53%
ACUTA CAPITAL PARTNERS, LLC 262,500$1,205,0000.51%
Tekla Capital Management LLC 898,374$4,124,0000.13%
Aristides Capital LLC 20,000$92,0000.04%
XTX Topco Ltd 13,499$62,0000.04%
Blackstone Inc. 1,678,984$7,707,0000.02%
Taylor Wealth Management Partners 11,635$53,0000.02%
Belvedere Trading LLC 96,486$255,0000.01%
View complete list of GALERA THERAPEUTICS INC shareholders